The success of SCT has led to the unfortunate complication of secondary malignancies in patients who would otherwise be long-term survivors. SCT survivors are at risk of developing therapy-related complications that may present years after treatment. These complications have surfaced as significant causes of increased mortality, and screening for some of these entities is advised in the hope that early detection may lead to better management. This presentation will discuss the importance of ongoing evaluation of the long-term SCT survivor.

Learning Objectives
At the end of this educational activity, participants should be able to

1. Discuss posttransplant malignancies in the SCT survivor, such as solid tumors, acute leukemia, myelodysplastic syndromes, and posttransplant lymphoproliferative disease (PTLD)
2. Review screening methods and the importance of ongoing evaluation for the long-term survivor

Method of Participation
There are no fees for participating in or receiving credit for this activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

Participants will receive a certificate upon successful completion of the activity, which includes the following:

• Completing the entire activity
• Completing the Pre- and Post-Activity Assessments, Activity Evaluation, and Application for Certificate of Credit forms

You must be logged in to your account to participate in this activity. Start by clicking “Begin” and viewing the “CE Info”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save, or print your certificate of participation. The Area of Practice you indicated in your profile corresponds with your certificate type. A complete listing of all of your activities can be found in your profile.

Method for Calculating CE Credit
CE credit was calculated by the complexity of content.

Faculty Listing
Shalini Shenoy, MD
Professor of Pediatrics
Attending Physician, Hematology, Oncology and General Pediatrics
Director, Pediatric Stem Cell Transplant Program
St. Louis Children's Hospital
St. Louis, Missouri

Disclosures
In accordance with the ACCME Standards for Commercial Support^SM, OptumHealth Education requires all those involved in the development of activity content to disclose their relevant financial relationships. An individual has a relevant financial relationship if such person (or their spouse/partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.
OptumHealth Education ensures that the content is independent of commercial bias.

Provided By
This activity is provided by OptumHealth Education.

Commercial Support
There was no commercial support received for this activity.

Hardware/Software Requirements
To view this activity you will need Internet Explorer 7.0+ or Firefox 3.0+ with Windows Media Player 9+, RealPlayer 12+, or Adobe Flash Player 9+. Be sure to disable your pop-up blocking software prior to the beginning of this activity.